Simple and non-invasive liver fibrosis stage prediction method

• Autorzy: Orczyk T. , Pałys M. , Porwik P. , Musialik J. , Błońska-Fajfrowska B.
• Języki publikacji: EN

Abstrakty

EN

In this paper a simple and non-expensive indirect fibrosis stage prediction method is described. Presented method is non-invasive and is based on the results of the generic blood tests. The method is based on a statistical analysis of wide range of blood tests results supported with the experience of hepatologists.

Słowa kluczowe

EN

liver fibrosis; hepatitis C; stage prediction

PL

zwłóknienie wątroby; wirusowe zapalenie wątroby typu C; przewidywanie etapu

• Wydawca: University of Silesia, Institute of Informatics, Computer Systems Department
• Czasopismo: Journal of Medical Informatics & Technologies
• Rocznik: 2011
• Tom: Vol. 17
• Strony: 227--231
• Opis fizyczny: Bibliogr. 9 poz., rys., tab.

Twórcy

autor

Orczyk T.

• University of Silesia, Institute of Computer Science, 41-200 Sosnowiec, Będzińska 39, Poland

autor

Pałys M.

autor

Porwik P.

autor

Musialik J.

autor

Błońska-Fajfrowska B.

Bibliografia

• [1] CASTÉRA L., Non invasive assessment of liver fibrosis in chronic hepatitis C. Liver International , Vol. 5, No. 2, 2011, pp. 625-634.
• [2] BioPredictive, http://www.biopredictive.com/intl/physician/fibrotest-for-hcv/view?set_language=pl.
• [3] Simens Medical, http://www.medical.siemens.com/webapp/wcs/stores/servlet/PSGenericDisplay~q_catalogId~e_-111~a_langId~e_-111~a_pageId~e_103713~a_storeId~e_10001.htm.
• [4] GOODMAN Z.D., Grading and staging systems for inflammation and fibrosis in chronic liver diseases, Journal of Hepatology, Vol. 47, No. 4, 2007, pp. 597-608.
• [5] Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis, The National Horizon Scanning Centre, Department of Public Health and Epidemiology, University of Birmingham, 2008.
• [6] WAI Ch-T., GREENSON J. K., FONTANA R. J., KALBFLEISCH J. D., MARRERO J. A., CONJEEVARAM H. S., LOK A. S-F., A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C, Hepatology, Vol. 38, No. 2, 2003, pp. 518-526.
• [7] CASTÉRA L., SEBASTIANI G., LE BAIL B., DE LÉDINGHEN V., COUZIGOU P., ALBERTI A., Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C, Journal of Hepatology, Vol. 52, 2010, pp. 191–198.
• [8] BOURLIERE M., PENARANDA G., OUZAN D., RENOU C., BOTTA-FRIDLUND D., TRAN A., ROSENTHAL E., WARTELLE-BLADOU C., DELASALLE P., OULES V., PORTAL I., CASTELLANI P., LECOMTE L., ROSENTHAL-ALLIERI M.A., HALFON P., Optimized stepwise combination algorithms of noninvasive liver fibrosis scores including Hepascore in hepatitis C virus patients, Alimentary Pharmacology & Therapeutics, Vol. 28, 2008, pp. 458–467.
• [9] BEDOSSA P., DARGÈRE D., PARADIS V., Sampling variability of liver fibrosis in chronic hepatitis C, Hepatology 2003, Vol. 38, pp. 1449–1457.